Map My Mole Wins Health Tech News Award

We’re over the moon to share that Map My Mole has been named Winner of the Most Promising Pilot at the 2025 HTN Health Tech Awards.
Written by
Sophie Bailey
Published on
November 24, 2025

We’re over the moon to share that Map My Mole has been named Winner of the Most Promising Pilot at the 2025 HTN Health Tech Awards - recognising our pioneering work in transforming access to early skin cancer detection.

“Great potential to improve patient outcomes and satisfaction.”
- Simon Moore, Associate Director of Procurement, Norfolk and Norwich University Hospitals NHS FT & HTN Awards Judge

A Radically Simple, Life-Saving Innovation

Map My Mole delivers a consultant-led mole checking service via smartphone and pharmacy — putting trusted skin assessments back into the hands of patients and their communities.

  • Patients receive a dermoscopic lens and use our app to capture clear images of skin lesions.
  • Images are reviewed by UK-based consultant dermatologists, with results typically returned in under 48 hours.
  • For those without smartphones or confidence, we provide community-based access via pharmacies and mobile healthcare assistants.

"This is an amazing example of how digital innovation can improve early detection access — and ultimately save lives."
— HTN Awards Judge

Pilot Results: Proving the Potential

Between March and June 2024, Map My Mole was piloted across three GP sites in Devon and Cornwall. The impact was immediate:

  • 1,126 cases reviewed
  • 989 GP appointments saved — freeing up 14,835 minutes of GP time
  • 64% reduction in two-week-wait referrals
  • 216 secondary care referrals avoided
  • Average time from submission to result: 1 day, 23 hours
  • 73% of patients were aged 55+
  • 62% of images were captured independently at home

These results show a scalable, equitable, and clinically safe model for early intervention - one that benefits GPs, patients, and the wider NHS.

Why This Matters

Skin cancer is one of the UK’s fastest-growing cancer types. GPs are overwhelmed, waiting lists are long, and many referrals don’t result in a diagnosis.

Map My Mole is changing the model:

  • Reducing avoidable referrals
  • Providing early reassurance
  • Catching more cancers, earlier
  • Making dermatology consultant access available in days, not months

Whether from a patient’s smartphone or in a high street pharmacy, this is teledermatology made accessible, affordable, and fast.

Looking Ahead

Winning the Most Promising Pilot is a huge milestone - and just the beginning.

“We’re over the moon to have won this award. It’s validation not just of our technology, but of our mission: to make early detection of skin cancer faster, fairer, and more accessible — for everyone.”
Toby Nelson, Co-Founder, Map My Mole

As we expand our partner sites in 2026, we’re inviting pharmacies, clinics, GPs, and insurers to join us in delivering consultant dermatology into the heart of every community.


------------------------------------

Join the Movement

Download the Map My Mole App
Apply to become a service provider
Help us put early detection on every high street

About Map My Mole
Map My Mole is a UK-based digital dermatology platform offering fast, consultant-reviewed skin assessments through smartphone-enabled mole checks. Its mission is to make early skin cancer detection accessible, affordable, and impactful.


Media Contact
Sophie Bailey

sophie@mapmymole.com

Stay up to date with our latest developments
Subscribe to our mailing list to get updates on the latest developments at Map My Mole
Thank you! You've been subscribed to updates from Map My Mole.
Oops! Something went wrong, please try again.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.